Pratt C B, Meyer W H, Rao B N, Pappo A S, Fleming I D, Luo X, Cain A, Kaste S C, Shearer P D, Jenkins J J
Department of Hematology-Oncology, St. Jude Children's Research Hospital, and The University of Tennessee, Memphis, College of Medicine, 38105, USA.
Cancer. 1997 Sep 15;80(6):1171-7.
The authors hypothesized that the outcomes for young patients who present with primary osteosarcoma of flat bones or secondary osteosarcoma after other primary malignancies are similar because the sites of these tumors rarely makes them amenable to complete surgical resection.
The authors reviewed their experience with 27 patients with primary osteosarcomas involving flat bones and 18 patients with secondary osteosarcomas of any site, evaluating treatment, metastatic patterns, and outcome.
Eleven of the 27 primary osteosarcomas and 10 of the 18 secondary osteosarcomas were at least partially resectable at the time of initial diagnosis. At last follow-up, 10 of the 27 patients with primary flat bone osteosarcoma were alive, eight of whom were disease free. Three of 18 with the secondary osteosarcoma patients were alive, including one with locally recurrent disease after recent disease resections. Chemotherapy with single or combinations of agents rarely yielded responses for primary flat bone or secondary osteosarcomas.
Outcome for both groups of patients was poor due to metastases and failure of local control. Sixteen of the 27 patients with primary osteosarcoma of flat bones died of their tumor; an additional patient died of doxorubicin-related cardiomyopathy and had microscopic disease in the primary site at autopsy. Thirteen of the 18 patients with secondary osteosarcoma died of their second metastatic cancer, 2 additional patients died of doxorubicin-related cardiomyopathy/coccidioidomycosis, and another of acute renal toxicity.
作者推测,因扁骨原发性骨肉瘤或其他原发性恶性肿瘤后继发性骨肉瘤就诊的年轻患者,其预后相似,因为这些肿瘤的部位很少能使其适合进行完整的手术切除。
作者回顾了他们对27例原发性骨肉瘤累及扁骨患者和18例任何部位继发性骨肉瘤患者的治疗经验,评估了治疗、转移模式和预后。
27例原发性骨肉瘤中有11例、18例继发性骨肉瘤中有10例在初次诊断时至少部分可切除。在最后一次随访时,27例原发性扁骨骨肉瘤患者中有10例存活,其中8例无疾病。18例继发性骨肉瘤患者中有3例存活,其中1例在近期疾病切除后出现局部复发。单药或联合用药化疗对原发性扁骨或继发性骨肉瘤很少产生反应。
由于转移和局部控制失败,两组患者的预后均较差。27例原发性扁骨骨肉瘤患者中有16例死于肿瘤;另有1例死于阿霉素相关心肌病,尸检时在原发部位有微小病变。18例继发性骨肉瘤患者中有13例死于其第二转移性癌症,另有2例死于阿霉素相关心肌病/球孢子菌病,还有1例死于急性肾毒性。